NEW DELHI: The federal government has negotiated value of Zydus Cadila‘s Covid vaccine ZyCoV-D with its producer and the vaccine will probably be quickly rolled out underneath the nationwide programme, an official stated.
Nonetheless, the needle free DNA-vaccine ZyCoV-D – which had been given emergency approval for restricted use in all above 12 years of age – will probably be given to kids solely after the Nationwide Technical Advisory Group on Immunisation (NTAGI) submits its detailed pointers for immunisation of youngsters in opposition to Covid-19.
“The negotiation with Zydus Cadila for pricing of ZyCoV-D are over and the procurement value has been mounted. The value is considerably decrease than what the corporate had quoted initially. The vaccine will probably be quickly administered as a part of the nationwide programme,” the official instructed TOI.
When requested whether or not it will even be administered to kids above 12 years of age, the official stated NTAGI is framing pointers to specify precedence teams. The vaccine will probably be initially out there just for these above 12 years age who’ve particular co-morbidities.